CONSORT diagram showing distribution of patients among cohorts upon initial enrollment, based on prior NGS performed on patient biopsies, and at final assignment after NGS of preenrollment biopsy and/or pSTAT3 IHC. Note that the final cohort for evaluation was 52 patients, as 1 patient in cohort 2 withdrew consent during the first week of treatment.